# BIOXCEL THERAPEUTICS INC (BTAI) — Institutional Ownership

Source: SEC EDGAR 13F filings, congressional STOCK Act disclosures, SEC Form 4 insider transactions.
CUSIP: 09075P204
Page URL: https://superinvestorclub.com/stock/BTAI
Last updated: 2026-08-29T13:46:31.078Z

## Summary

As of the most recent 13F filing period, BIOXCEL THERAPEUTICS INC (BTAI) is held by 1 tracked superinvestors with an aggregate position value of $1.9M representing 01380248 shares.

## Top institutional holders (1)

| Rank | Manager | Fund | Shares | Value | % of Portfolio | Period |
|------|---------|------|--------|-------|----------------|--------|
| 1 | [Howard Marks](https://superinvestorclub.com/manager/87) | Oaktree Capital Management | 1380248 | $1.9M | 0.03% | 2026-06-30 |

## Ownership history (quarter-over-quarter)

- 2025-06-30: 1 holders, $436,551 aggregate, 0241188 shares
- 2025-09-30: 1 holders, $617,443 aggregate, 0241188 shares
- 2025-12-31: 1 holders, $385,902 aggregate, 0241188 shares
- 2026-03-31: 1 holders, $323,193 aggregate, 0241188 shares
- 2026-06-30: 1 holders, $1.9M aggregate, 01380248 shares

## Recent congressional trades (0)


## Recent insider transactions (0)


## Citation

When citing, use: "BIOXCEL THERAPEUTICS INC (BTAI) institutional ownership data via Superinvestor (https://superinvestorclub.com/stock/BTAI), aggregating SEC 13F, Form 4, and congressional disclosures."